Literature DB >> 1982294

Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy.

R M McDouall1, M J Dunn, V Dubowitz.   

Abstract

Normal skeletal muscle does not express class I MHC antigens. In contrast, these antigens are strongly expressed at the periphery of muscle fibres in patients with juvenile dermatomyositis (JDM) and Duchenne muscular dystrophy (DMD). Interferons can induce the expression of class I antigens, but in this study interferon-gamma could not be detected in JDM muscle biopsy specimens using four different immunocytochemical techniques. However, an infiltrate of mononuclear cells capable of synthesising interferons was present in biopsies from JDM and DMD patients. The predominant cell types detected in both diseases were macrophages and T lymphocytes, these two cell types comprising more than 80% of the infiltrating mononuclear cells. A striking predominance of CD4+ helper/inducer T cells was observed. The majority of these cells expressed class II MHC antigens and were, therefore, considered to be activated. Additional evidence for the functional activity of CD4+ T cells was derived from the finding that it was this population of cells from JDM biopsies which proliferated in response to interleukin-2 in vitro. T cell subsets in peripheral blood were also investigated in JDM and DMD patients. Only in the case of JDM were any significant differences from normal observed, where a significant reduction in the number of peripheral blood CD8+ T cells resulted in an elevation of CD4+/CD/8+ ratios. The role of CD4+ T cells and aberrant class I MHC antigen expression in mediating muscle damage in JDM and DMD is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982294     DOI: 10.1016/0022-510x(90)90156-h

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  43 in total

Review 1.  Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis.

Authors:  Lauren M Pachman; Adele L Boskey
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

2.  The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.

Authors:  Mahmoud R Hussein; Sherifa A Hamed; Mohammed G Mostafa; Eman E Abu-Dief; Nageh Fouly Kamel; Mahmoud R Kandil
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

Review 3.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

4.  Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging.

Authors:  Tina Wenz; Susana G Rossi; Richard L Rotundo; Bruce M Spiegelman; Carlos T Moraes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

5.  Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions.

Authors:  I S McLennan
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

6.  Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.

Authors:  Jamie Morrison; Donald B Palmer; Stephen Cobbold; Terence Partridge; George Bou-Gharios
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 7.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

8.  Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-κB in muscle of mdx mice.

Authors:  Rakshita A Charan; Gabriela Niizawa; Hiroyuki Nakai; Paula R Clemens
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

Review 9.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

10.  Partial least squares based identification of Duchenne muscular dystrophy specific genes.

Authors:  Hui-bo An; Hua-cheng Zheng; Li Zhang; Lin Ma; Zheng-yan Liu
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.